Carol Sheppard

Carol Sheppard

Auto-generated profile, based on publicly available information

Carol Sheppard

Department of infectious disease, Imperial College London, London, UK

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
AIAlewo Idoko-Akoh
Alewo Idoko-Akoh
DGDaniel H. Goldhill
Daniel H. Goldhill
CSCarol M. Sheppard
Carol M. Sheppard
DBDagmara Bialy
Dagmara Bialy
JQJessica L. Quantrill
Jessica L. Quantrill
MMMike J. McGrew
Mike J. McGrew
Chickens genetically resistant to avian influenza could prevent future outbreaks. In chickens, influenza A virus (IAV) relies on host protein ANP32A. Here we use CRISPR/Cas9 to generate homozygous gene edited (GE) chickens containing two ANP32A amino acid substitutions that prevent viral polymerase interaction. After IAV challenge, 9/10 edited chickens remain uninfected. Challenge with a higher dose, however, led to breakthrough infections. Breakthrough IAV virus contained IAV polymerase gene mutations that conferred adaptation to the edited chicken ANP32A. Unexpectedly, this virus also replicated in chicken embryos edited to remove the entire ANP32A gene and instead co-opted alternative ANP32 protein family members, chicken ANP32B and ANP32E. Additional genome editing for removal of ANP32B and ANP32E eliminated all viral growth in chicken cells. Our data illustrate a first proof of concept step to generate IAV-resistant chickens and show that multiple genetic modifications will be required to curtail viral escape.

1 September 2019 in Journal of Virology
Verified
Journal Article
Open access
PDF file
ESEcco Staller
Ecco Staller
CSCarol M. Sheppard
Carol M. Sheppard
PNPeter J. Neasham
Peter J. Neasham
BMBhakti Mistry
Bhakti Mistry
TPThomas Peacock
Thomas Peacock
WBWendy S. Barclay
Wendy S. Barclay
Influenza virus is the etiological agent behind some of the most devastating infectious disease pandemics to date, and influenza outbreaks still pose a major threat to public health. Influenza virus polymerase, the molecule that copies the viral RNA genome, hijacks cellular proteins to support its replication. Current anti-influenza drugs are aimed against viral proteins, including the polymerase, but RNA viruses like influenza tend to become resistant to such drugs very rapidly. An alternative strategy is to design therapeutics that target the host proteins that are necessary for virus propagation. Here, we show that the human proteins ANP32A and ANP32B are essential for influenza A and B virus replication, such that in their absence cells become impervious to the virus. We map the proviral activity of ANP32 proteins to one region in particular, which could inform future intervention.

31 May 2023 in Journal of Virology
Verified
Journal Article
Open access
TPThomas Peacock
Thomas Peacock
CSCarol M. Sheppard
Carol M. Sheppard
MLMargaret G. Lister
Margaret G. Lister
ESEcco Staller
Ecco Staller
RFRebecca Frise
Rebecca Frise
WBWendy S. Barclay
Wendy S. Barclay
Influenza viruses naturally reside in wild aquatic birds. However, the high mutation rate of influenza viruses allows them to rapidly and frequently adapt to new hosts, including mammals.

28 May 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
TPThomas Peacock
Thomas Peacock
CSCarol M. Sheppard
Carol M. Sheppard
JBJonathan C. Brown
Jonathan C. Brown
NGNiluka Goonawardane
Niluka Goonawardane
JZJie Zhou
Jie Zhou
WBWendy S. Barclay
Wendy S. Barclay
The spike (S) glycoprotein of the SARS-CoV-2 virus that emerged in 2019 contained a suboptimal furin cleavage site at the S1/S2 junction with the sequence 681 P RR A R /S 686 . This cleavage site is required for efficient airway replication, transmission, and pathogenicity of the virus. The B.1.617 lineage has recently emerged in India, coinciding with substantial disease burden across the country. Early evidence suggests that B.1.617.2 (a sublineage of B.1.617) is more highly transmissible than contemporary lineages. B.1.617 and its sublineages contain a constellation of S mutations including the substitution P681R predicted to further optimise this furin cleavage site. We provide experimental evidence that virus of the B.1.617 lineage has enhanced S cleavage, that enhanced processing of an expressed B.1.617 S protein in cells is due to P681R, and that this mutation enables more efficient cleavage of a peptide mimetic of the B.1.617 S1/S2 cleavage site by recombinant furin. Together, these data demonstrate viruses in this emerging lineage have enhanced S cleavage by furin which we hypothesise could be enhancing transmissibility and pathogenicity.

15 May 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
ESEcco Staller
Ecco Staller
LCLoïc Carrique
Loïc Carrique
OSOlivia C. Swann
Olivia C. Swann
HFHaitian Fan
Haitian Fan
JRJeremy Russell
Jeremy Russell
EFErvin Fodor
Ervin Fodor
Avian influenza A viruses (IAVs) pose a public health threat, as they are capable of triggering pandemics by crossing species barriers. Replication of avian IAVs in mammalian cells is hindered by species-specific variation in acidic nuclear phosphoprotein 32 (ANP32) proteins, which are essential for viral RNA genome replication. Adaptive mutations enable the IAV RNA polymerase (FluPolA) to surmount this barrier. Here, we present cryo-electron microscopy structures of monomeric and dimeric avian H5N1 FluPolA with human ANP32B. ANP32B interacts with the PA subunit of FluPolA in the monomeric form, at the site used for its docking onto the C-terminal domain of host RNA polymerase II during viral transcription. ANP32B acts as a chaperone, guiding FluPolA towards a ribonucleoprotein-associated FluPolA to form an asymmetric dimer—the replication platform for the viral genome. These findings offer insights into the molecular mechanisms governing IAV genome replication, while enhancing our understanding of the molecular processes underpinning mammalian adaptations in avian-origin FluPolA.

29 September 2019 in Annual Review of Virology
Verified
Journal Article
Closed access
TPThomas Peacock
Thomas Peacock
CSCarol M. Sheppard
Carol M. Sheppard
ESEcco Staller
Ecco Staller
WBWendy S. Barclay
Wendy S. Barclay
Influenza viruses are a leading cause of seasonal and pandemic respiratory illness. Influenza is a negative-sense single-stranded RNA virus that encodes its own RNA-dependent RNA polymerase (RdRp) for nucleic acid synthesis. The RdRp catalyzes mRNA synthesis, as well as replication of the virus genome (viral RNA) through a complementary RNA intermediate. Virus propagation requires the generation of these RNA species in a controlled manner while competing heavily with the host cell for resources. Influenza virus appropriates host factors to enhance and regulate RdRp activity at every step of RNA synthesis. This review describes such host factors and summarizes our current understanding of the roles they play in viral synthesis of RNA.